Published in Heart Disease Weekly, November 7th, 2004
According to the report from Italy, "The GISSI Heart Failure project is a large-scale, randomized, double-blind study designed to investigate the effects of n-3 polyunsaturated fatty acids and rosuvastatin on mortality and morbidity in patients with symptomatic heart failure."
L. Tavazzi and colleagues of the Policlinico San Matteo in Pavia explained, "Patients with New York Heart Association classes II to IV heart failure, already receiving optimized recommended therapy, will be recruited in a nationwide network of more than 300 cardiology and internal medicine...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Heart Disease Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.